Nurse Practitioner, Adult Health · New York, NY
NPI
1942919022
Since 2022
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 E 70th St Ste 341
New York, NY, 10021
Phone (720) 435-6573
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,319
23 services
Medicare patients, 2024
21
Average age 74
Drug cost, 2024
$1.0M
338 prescriptions
Company payments, 2025
$1,642
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle Vasquez was code 38222 (other organ systems), 16 times for 16 patients. In total Michelle Vasquez billed 23 services in 4 codes, and Medicare paid $1,319.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 38222 Other Organ Systems | Facility | 16 | 16 | $53.80 | $861 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Vasquez prescribed most often to Medicare patients was Venclexta (Venetoclax), with 23 prescriptions and refills. In total Michelle Vasquez wrote 338 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 23 | 24 | Under 11 | $95K |
| Valacyclovir Valacyclovir Hcl | 21 | 27 | 12 | $423 |
| Aminocaproic Acid Generic | 14 | 14 | Under 11 | $25K |
| Levofloxacin Generic | 13 | 13 | 11 | $205 |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $180K |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $952 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 13 | Under 11 | $58.07 |
| Dexamethasone Generic | 11 | 11 | Under 11 | $192 |
| Inqovi Decitabine/Cedazuridine | 11 | 11 | Under 11 | $91K |
| Allopurinol Generic | 11 | 25 | Under 11 | $119 |
Brand drugs: 85 claims; generic drugs: 253 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle Vasquez $1,642 ($1,642 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $260.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $260 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $241 |
| Legend Biotech USA Inc. LEGN | 1 | $149 |
| Janssen Biotech, Inc. JNJ | 1 | $125 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $125 |
| GlaxoSmithKline, LLC. GSK | 1 | $125 |
| Kite Pharma, Inc. GILD | 1 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $98.07 |
| Sobi, Inc SOBI.ST | 2 | $62.45 |
| Azurity Pharmaceuticals, Inc. | 2 | $60.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.